Dr. Reddy's Laboratories Limited (ADR)
General ticker "RDY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $11.8B (TTM average)
Dr. Reddy's Laboratories Limited (ADR) follows the US Stock Market performance with the rate: 26.4%.
Estimated limits based on current volatility of 0.5%: low 14.05$, high 14.18$
Factors to consider:
- Company pays dividends (annually): last record date 2025-07-10, amount 0.09$ (Y0.64%)
- Total employees count: 5852 as of 2003
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [11.18$, 18.24$]
- 2025-03-31 to 2026-03-31 estimated range: [10.34$, 17.24$]
Financial Metrics affecting the RDY estimates:
- Positive: with PPE of 18.2 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 24.26 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: 0.33 < Operating cash flow per share per price, % of 4.45
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.56 > 6.04
- Negative: Investing cash flow per share per price, % of -3.95 <= -0.66
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Interest expense per share per price, % of 0.17 <= 0.79
Short-term RDY quotes
Long-term RDY plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | INR245,879.00MM | INR279,164.00MM | INR325,535.00MM |
| Operating Expenses | INR188,735.00MM | INR211,435.00MM | INR253,692.00MM |
| Operating Income | INR57,144.00MM | INR67,729.00MM | INR71,843.00MM |
| Non-Operating Income | INR3,223.00MM | INR4,141.00MM | INR4,941.00MM |
| Interest Expense | INR1,428.00MM | INR1,711.00MM | INR2,829.00MM |
| R&D Expense | INR19,381.00MM | INR22,873.00MM | INR27,380.00MM |
| Income(Loss) | INR60,367.00MM | INR71,870.00MM | INR76,784.00MM |
| Taxes | INR15,300.00MM | INR16,186.00MM | INR19,539.00MM |
| Profit(Loss)* | INR45,067.00MM | INR55,684.00MM | INR56,544.00MM |
| Stockholders Equity | INR230,991.00MM | INR280,550.00MM | INR333,388.00MM |
| Inventory | INR48,670.00MM | INR63,552.00MM | INR71,085.00MM |
| Assets | INR321,854.00MM | INR387,518.00MM | INR492,989.00MM |
| Operating Cash Flow | INR58,875.00MM | INR45,433.00MM | INR46,428.00MM |
| Capital expenditure | INR18,866.00MM | INR27,435.00MM | INR34,398.00MM |
| Investing Cash Flow | INR-41,373.00MM | INR-40,283.00MM | INR-58,077.00MM |
| Financing Cash Flow | INR-26,861.00MM | INR-3,763.00MM | INR18,911.00MM |
| Earnings Per Share** | INR54.29 | INR66.80 | INR67.85 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.